LentiArray™ CRISPR 阴性对照慢病毒，人，非靶向
Product Image
引用和文献 (1)
Invitrogen™

LentiArray™ CRISPR 阴性对照慢病毒，人，非靶向

Negative control gRNAs are essential in screening applications for setting thresholds for hit determination. The Invitrogen™ LentiArray™ CRISPR Negative Control了解更多信息
Have Questions?
货号数量
A323271 mL
货号 A32327
价格（CNY)
-
数量:
1 mL
Negative control gRNAs are essential in screening applications for setting thresholds for hit determination. The Invitrogen™ LentiArray™ CRISPR Negative Control Lentivirus, Human Scrambled, contains a gRNA sequence with no sequence homology to any region of the human genome.
仅供科研使用。不可用于诊断程序。
规格
适用于（应用）基因组编辑
产品线LentiArray
产品类型gRNA
数量1 mL
运输条件干冰
控制类型阴性对照品
产品规格管装
RNAi 类型gRNA
种属人
Unit SizeEach
内容与储存
1 x 1 mL。在 -68 至 -85°C 下储存。

引用和文献 (1)

引用和文献
Abstract
A functional screening of the kinome identifies the Polo-like kinase 4 as a potential therapeutic target for malignant rhabdoid tumors, and possibly, other embryonal tumors of the brain.
Authors:Sredni ST, Suzuki M, Yang JP, Topczewski J, Bailey AW, Gokirmak T, Gross JN, de Andrade A, Kondo A, Piper DR, Tomita T
Journal:Pediatr Blood Cancer
PubMed ID:28398638
Malignant rhabdoid tumors (MRTs) are deadly embryonal tumors of the infancy. With poor survival and modest response to available therapies, more effective and less toxic treatments are needed. We hypothesized that a systematic screening of the kinome will reveal kinases that drive rhabdoid tumors and can be targeted by specific ... More